-
Breast cancer diagnoses fell sharply during pandemic: Study
Breast cancer diagnoses dropped 15.7% for women and 21.8% for men during the pandemic, according to a study involving nearly 1.5 million patients. -
3 Chicago systems partner to launch cancer initiative
Three Chicago health systems have collaborated with a nonprofit foundation to launch the Chicago Breast Cancer Research Consortium. -
2 things that 'alarm' this cancer leader
It was a feeling of helplessness that led Mark Evers, MD, a gastrointestinal surgeon, to pursue cancer research. -
Risk of cancer elevated by metabolic syndrome
Patients with metabolic syndrome have an increased risk for developing various types of cancer, according to new research from Gateway for Cancer Research, a nonprofit group based in Schaumburg, Ill. -
The healthiest habits oncologists keep
Nearly half of oncologists said they use the internet for more than four hours every day for professional reasons, a recent Medscape survey found. -
New guidelines for prostate screenings for Black men
The Prostate Cancer Foundation released new guidelines for prostate-specific antigen-based screening in Black men. -
Change's oncology services to be restored, but hassles for providers will continue
The cyberattack on Change has some cancer centers scrambling to find money for chemotherapy to avoid delaying treatment, but Change said it plans to have cancer services up and running this week, The New York Times reported March 5. -
Morehouse School of Medicine wins $25M to study cancer disparities
A research team based at Morehouse School of Medicine in Atlanta has been selected as one of five teams globally to receive a multimillion-dollar award, which it will put toward studies to address cancer disparities among populations of African descent. -
FDA OKs 1st drug for this lung cancer mutation
The FDA approved a new drug for first-line lung cancer treatment. -
Florida cancer center gets $50M gift
Miami-based Sylvester Comprehensive Cancer Center received a $50 million gift from Kenneth Griffin, founder and CEO of Citadel and founder of Griffin Catalyst. -
Blocking this protein could help prevent 40% of uterine cancer deaths
Uterine cancer is the only cancer that has seen survival rates continuously fall in the last 40 years, but research published March 4 in the British Journal of Cancer suggests that using a medication to block a protein called Galectin-3 could be a more effective treatment. -
$43M spent each year on this overused cancer drug: Study
Denosumab, a bone-modifying agent for cancer treatment, is being overused and costing Medicare more than $43 million each year, a recent Memorial Sloan Kettering study found. -
Behavioral health's impact on cancer surgery outcomes
Cancer patients who undergo surgery and have a behavioral health disorder have higher odds of a complication, prolonged length of stay and 90-day readmission, a recent study found. -
American Cancer Society unveils credentialing program for patient navigation
The American Cancer Society has launched a national training and credentialing program to support cancer institutions in advancing patient navigation services. -
World's best oncology hospitals, per Newsweek
Five of the top 10 oncology hospitals in the world are based in the U.S., according to Newsweek's 2024 "World's Best Specialized Hospitals" list. -
Moffitt Cancer Center names physician of the year
Tampa, Fla.-based Moffitt Cancer Center named Jonathan Zager, MD, physician of the year. -
Becoming an innovation leader: Lessons from Community Health Network’s multi-cancer early detection testing program
Indianapolis-based Community Health Network is a nonprofit health system with more than 200 sites of care. Having served patients in central Indiana for more than 60 years, the organization has deep ties to the areas it serves. -
From Holland to the US: What keeps this City of Hope leader excited about cancer care
Marcel van den Brink, MD, PhD, started his career in "the real Holland with the windmills, tulip fields and all that good stuff." But he left all of it behind in the late 1980s to complete his oncology training in the United States. -
Cancer patients' reproductive options in doubt after Alabama IVF ruling
A recent Alabama Supreme Court ruling that frozen embryos are considered children under the law has worried cancer patients who use in vitro fertilization to preserve their reproductive options, The Washington Post reported Feb. 25. -
'Discrepancies' in Providence pathologist's work led to delayed cancer diagnoses: Report
Providence has confirmed a pathologist is no longer providing services at the system after finding "discrepancies" with their work. This comes as at least seven patients have reported their lab results were incorrectly reviewed by the same pathologist.
Page 19 of 50